QA: Celularity Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001752828_2022_Celularity_Inc.pdf

Logs

warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 0.8220122894285834, 'aggregate_val': 43588000, 'exp_sum': 23923000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 66021000, 'ResearchAndDevelopmentExpense': 78363000, 'remainder_Expenses': -120461000}}

Graph

Absolute values for 0001752828, Celularity Inc

  xvar xval
0 AssetsCurrent 59,100,000
1 IntangibleAssetsNetIncludingGoodwill 246,491,000
2 PropertyPlantAndEquipmentNet 90,625,000
3 remainder_Assets 17,912,000
4 LiabilitiesCurrent 26,225,000
5 LiabilitiesNoncurrent 2,206,000
6 remainder_Liabilities 286,279,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 71,341,000
9 ResearchAndDevelopmentExpense 88,353,000
10 remainder_Expenses -29,280,000
11 remainder_Revenues 21,335,000
12 remainder_NetIncome 8,961,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 414,128,000
1 Liabilities 314,710,000
2 Expenses 130,414,000
3 Revenues 21,335,000
4 StockholdersEquity 99,418,000
5 NetIncome -100,118,000
6 ComprehensiveNetIncome -100,118,000
7 BaseVar 444,774,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.320
9 EconomicCapitalRatio 1.72

Edgar->Model Mapping

Feature Distribution